Humacyte, Inc. (HUMA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 495K | 467K | 753K | 301K | 517K | 7.23M | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | -4.26% | -93.54% | - | - | - | - | - | - | - | - | -100% | -100% |
| Cost of Goods Sold | 2.04M | 10.87M | 2.13M | 2.07M | 1.98M | 3.61M | 1.81M | 1.82M | 1.79M | 3.38M | 1.31M | 20.54M |
| COGS % of Revenue | 411.72% | 2327.62% | 282.2% | 688.7% | 382.79% | 50% | - | - | - | - | - | - |
| Gross Profit | -1.54M | -10.4M | -1.37M | -1.77M | -1.46M | 3.61M | -1.81M | -1.82M | -1.79M | -3.38M | -1.31M | -20.54M |
| Gross Margin % | -311.72% | -2227.62% | -182.2% | -588.7% | -282.79% | 50% | - | - | - | - | - | - |
| Gross Profit Growth % | -5.54% | -387.85% | 24.28% | 2.8% | 18.37% | 206.99% | -37.79% | 91.12% | - | 77.42% | 34.77% | -53.85% |
| Operating Expenses | 27.39M | 20.43M | 23.02M | 27.95M | 21.72M | 31.7M | 28.42M | 27.68M | 24.79M | 22.8M | 23.31M | 6.19M |
| OpEx % of Revenue | 5533.74% | 4375.37% | 3056.84% | 9287.38% | 4201.55% | 438.6% | - | - | - | - | - | - |
| Selling, General & Admin | 7.93M | 5.83M | 5.75M | 7.81M | 8.14M | 11.05M | 7.31M | 3.92M | 3.52M | 2.62M | 6.07M | 3.08M |
| SG&A % of Revenue | 1602.02% | 1247.97% | 762.95% | 2594.35% | 1573.69% | 152.82% | - | - | - | - | - | - |
| Research & Development | 19.46M | 14.61M | 17.27M | 22.01M | 15.42M | 20.66M | 22.93M | 23.75M | 21.26M | 20.18M | 18.55M | 20.54M |
| R&D % of Revenue | 3931.72% | 3127.41% | 2293.89% | 7310.96% | 2982.2% | 285.78% | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | -1000K | -1000K |
| Operating Income | -28.93M | -30.84M | -24.39M | -29.73M | -23.18M | -28.09M | -30.23M | -29.5M | -26.58M | -26.18M | -24.62M | -26.73M |
| Operating Margin % | -5845.45% | -6603% | -3239.04% | -9876.08% | -4484.33% | -388.6% | - | - | - | - | - | - |
| Operating Income Growth % | -24.81% | -9.78% | 19.33% | -0.77% | 12.77% | -7.28% | -22.79% | -10.36% | -18.06% | -25.94% | -4.8% | -44.25% |
| EBITDA | -27.14M | -29.05M | -22.52M | -27.87M | -21.35M | -26.28M | -28.42M | -27.68M | -24.79M | -22.8M | -23.31M | -24.75M |
| EBITDA Margin % | -5483.84% | -6220.13% | -2991.37% | -9258.14% | -4129.98% | -363.59% | - | - | - | - | - | - |
| EBITDA Growth % | -27.13% | -10.53% | 20.75% | -0.69% | 13.86% | -15.24% | -21.94% | -11.83% | -21.27% | -22.1% | -8.67% | -49.9% |
| D&A (Non-Cash Add-back) | 1.79M | 1.79M | 1.86M | 1.86M | 1.83M | 1.81M | 1.81M | 1.82M | 1.79M | 3.38M | 1.31M | 1.98M |
| EBIT | -28.93M | -30.84M | -24.39M | -35.11M | 42.14M | -18.43M | -36.76M | -54.15M | -30.08M | -23.38M | -24.53M | -23.62M |
| Net Interest Income | -1.94M | -2.59M | -2.02M | -1.71M | -2.34M | -1.66M | -1.53M | -1.21M | -785K | -583K | -94K | -231K |
| Interest Income | 330K | 503K | 590K | 832K | 662K | 852K | 911K | 1.31M | 1.03M | 1.14M | 1.37M | 1.48M |
| Interest Expense | 2.27M | 3.09M | 2.61M | 2.54M | 3M | 2.51M | 2.44M | 2.52M | 1.82M | 1.73M | 1.46M | 1.71M |
| Other Income/Expense | 11.32M | 6.03M | 6.88M | -7.93M | 62.32M | 7.15M | -8.97M | -27.16M | -5.32M | 1.08M | -1.37M | 4.03M |
| Pretax Income | -17.62M | -24.8M | -17.51M | -37.66M | 39.14M | -20.94M | -39.2M | -56.66M | -31.9M | -25.11M | -26M | -22.71M |
| Pretax Margin % | -3559.39% | -5311.35% | -2325.37% | -12510.96% | 7570.41% | -289.71% | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -17.62M | -24.8M | -17.51M | -37.66M | 39.14M | -20.94M | -39.2M | -56.66M | -31.9M | -25.11M | -26M | -22.71M |
| Net Margin % | -3559.39% | -5311.35% | -2325.37% | -12510.96% | 7570.41% | -289.71% | - | - | - | - | - | - |
| Net Income Growth % | -145.02% | -18.45% | 55.33% | 33.54% | 222.71% | 16.59% | -50.81% | -149.55% | 13.72% | -574.89% | -2.82% | -161.59% |
| Net Income (Continuing) | -17.62M | -24.8M | -17.51M | -37.66M | 39.14M | -20.94M | -39.2M | -56.66M | -31.9M | -25.11M | -26M | -22.71M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | -0.15 | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 | -0.22 |
| EPS Growth % | -131.79% | 6.25% | 66.67% | 50% | 196.55% | 33.33% | -32% | -118.18% | 51.67% | -284.62% | 0% | -162.86% |
| EPS (Basic) | -0.09 | -0.15 | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 | -0.22 |
| Diluted Shares Outstanding | 197.85M | 158.16M | 158.31M | 155.44M | 131.76M | 118.48M | 119.41M | 119.17M | 108.25M | 103.61M | 103.44M | 103.36M |
| Basic Shares Outstanding | 197.85M | 158.16M | 158.31M | 155.44M | 131.5M | 118.48M | 119.41M | 119.17M | 108.25M | 103.61M | 103.44M | 103.36M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |